Literature DB >> 26873016

Clinicopathological Features and Long-Term Outcomes of Intraductal Papillary Neoplasms of the Intrahepatic Bile Duct.

Wan-Joon Kim1, Shin Hwang2, Yong-Joo Lee1, Ki-Hun Kim1, Kwang-Min Park1, Chul-Soo Ahn1, Deok-Bog Moon1, Tae-Yong Ha1, Gi-Won Song1, Dong-Hwan Jung1, Gil-Chun Park1, Myeong-Hwan Kim3, Sung-Koo Lee3, Dong Wan Seo3, Do Hyun Park3, Sang Soo Lee3, Sung-Gyu Lee1.   

Abstract

We intended to investigate the clinicopathological features of intrahepatic intraductal papillary neoplasms of the bile duct (IPNB), especially their malignant features and post-resection prognosis. Forty-three patients who met the definition of IPNB and who underwent liver resection between January 2002 and June 2015 were selected from our institutional database of liver resection cases. The mean age was 63.3 ± 6.9 years and 24 were male. Hepatolithiasis was present in addition in 10 of the patients. Left- and right-sided hepatectomies and concurrent bile duct resection (BDR) were performed in 28, 15, and 10 patients, respectively; R0 resection was performed in 37 patients. The mean tumor diameter was 4.1 ± 2.2 cm. Histological tumor grade was low in 4 cases, intermediate in 6, and malignant in 33. There was no cancer-related recurrence or death in the 10 patients with low-grade or intermediate lesions. In the 33 patients with malignant lesions, rates of tumor recurrence and overall survival were 12.5 and 96.2 % at 1 year, 36.4 and 91.3 % at 3 years, and 47.0 and 68.8 % at 5 years, respectively. Multivariate analysis showed that R1 resection was the only prognostic factor for tumor recurrence and patient survival. BDR was performed in only 2 of 6 patients undergoing R1 resection. Intrahepatic IPNB is a rare type of biliary neoplasm that encompasses a histological spectrum ranging from benign disease to invasive malignancy. Long-term survival was anticipated after curative resection. R1 resection reduced survival outcomes; therefore, we suggest that concurrent BDR should be performed if the resection margin of the bile duct is not reliably free of neoplastic involvement.

Entities:  

Keywords:  Adenoma; Intraductal growth; Intrahepatic cholangiocarcinoma; Papillary growth

Mesh:

Year:  2016        PMID: 26873016     DOI: 10.1007/s11605-016-3103-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  22 in total

1.  The clinicopathological features of intraductal papillary neoplasms of the bile duct in a Chinese population.

Authors:  Jian Yang; Wentao Wang; Lunan Yan
Journal:  Dig Liver Dis       Date:  2011-09-17       Impact factor: 4.088

2.  Prognostic Impact of Tumor Growth Type on 7th AJCC Staging System for Intrahepatic Cholangiocarcinoma: a Single-Center Experience of 659 Cases.

Authors:  Shin Hwang; Young-Joo Lee; Gi-Won Song; Kwang-Min Park; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2015-03-28       Impact factor: 3.452

3.  Quantified Risk Assessment for Major Hepatectomy via the Indocyanine Green Clearance Rate and Liver Volumetry Combined with Standard Liver Volume.

Authors:  Shin Hwang; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Chul-Soo Ahn; Deok-Bog Moon; Ki-Hun Kim; Young-Joo Lee; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2015-05-07       Impact factor: 3.452

4.  Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?

Authors:  Flavio G Rocha; Hwajeong Lee; Nora Katabi; Ronald P DeMatteo; Yuman Fong; Michael I D'Angelica; Peter J Allen; David S Klimstra; William R Jarnagin
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

5.  Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion.

Authors:  Masayuki Ohtsuka; Fumio Kimura; Hiroaki Shimizu; Hiroyuki Yoshidome; Atsushi Kato; Hideyuki Yoshitomi; Katsunori Furukawa; Dan Takeuchi; Tsukasa Takayashiki; Kosuke Suda; Shigetsugu Takano; Yoichiro Kondo; Masaru Miyazaki
Journal:  Am J Surg Pathol       Date:  2011-04       Impact factor: 6.394

6.  Pathological classification of intrahepatic cholangiocarcinoma based on a new concept.

Authors:  Yasuni Nakanuma; Yasunori Sato; Kenichi Harada; Motoko Sasaki; Jing Xu; Hiroko Ikeda
Journal:  World J Hepatol       Date:  2010-12-27

7.  Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.

Authors:  Geunyoung Jung; Kwang-Min Park; Seung Soo Lee; Eunsil Yu; Seung-Mo Hong; Jihun Kim
Journal:  J Hepatol       Date:  2012-05-23       Impact factor: 25.083

8.  Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".

Authors:  Yasuni Nakanuma; Yasunori Sato; Hidenori Ojima; Yae Kanai; Shinichi Aishima; Masakazu Yamamoto; Shun-ichi Ariizumi; Toru Furukawa; Hiroki Hayashi; Michiaki Unno; Tetsuo Ohta
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 9.  Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: an immunohistochemical approach.

Authors:  Yasuni Nakanuma; Yoh Zen; Kenichi Harada; Hiroko Ikeda; Yasunori Sato; Takeshi Uehara; Motoko Sasaki
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-08-14       Impact factor: 7.027

10.  Intraductal neoplasm of the intrahepatic bile duct: clinicopathological study of 24 cases.

Authors:  Yoshiki Naito; Hironori Kusano; Osamu Nakashima; Eiji Sadashima; Satoshi Hattori; Tomoki Taira; Akihiko Kawahara; Yoshinobu Okabe; Kazuhide Shimamatsu; Jun Taguchi; Seiya Momosaki; Koji Irie; Rin Yamaguchi; Hiroshi Yokomizo; Michiko Nagamine; Seiji Fukuda; Shinichi Sugiyama; Naoyo Nishida; Koichi Higaki; Munehiro Yoshitomi; Masafumi Yasunaga; Koji Okuda; Hisafumi Kinoshita; Masamichi Nakayama; Makiko Yasumoto; Jun Akiba; Masayoshi Kage; Hirohisa Yano
Journal:  World J Gastroenterol       Date:  2012-07-28       Impact factor: 5.742

View more
  12 in total

1.  CK20 and lymph node involvement predict adverse outcome of malignant intraductal papillary neoplasm of the bile duct.

Authors:  Jie Shi; Xueshuai Wan; Yuan Xie; Jianzhen Lin; Junyu Long; Weiyu Xu; Zhiyong Liang; Xinting Sang; Haitao Zhao
Journal:  Histol Histopathol       Date:  2019-10-28       Impact factor: 2.303

2.  Prognostic Factors for Surgically Resected Intraductal Papillary Neoplasm of the Bile Duct: A Retrospective Cohort Study.

Authors:  Shuichiro Uemura; Ryota Higuchi; Takehisa Yazawa; Wataru Izumo; Yutaro Matsunaga; Masahiro Shiihara; Takehiro Ota; Toru Furukawa; Masakazu Yamamoto
Journal:  Ann Surg Oncol       Date:  2020-07-10       Impact factor: 5.344

Review 3.  Cystic biliary tumors of the liver: diagnostic criteria and common pitfalls.

Authors:  Susan Shyu; Aatur D Singhi
Journal:  Hum Pathol       Date:  2020-12-28       Impact factor: 3.526

4.  Intraductal papillary mucinous neoplasm of the biliary tract with cardiac metastasis: A case report.

Authors:  Joo Hyung Lee; Hyung Sun Kim; Ji Hyun Park; Joon Seong Park
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

5.  Serum IgG as a Marker for Opisthorchis viverrini-Associated Cholangiocarcinoma Correlated with HER2 Overexpression.

Authors:  Attapol Titapun; Anchalee Techasen; Prakasit Sa-Ngiamwibool; Paiboon Sithithaworn; Vor Luvira; Tharatip Srisuk; Apiwat Jareanrat; Hasaya Dokduang; Watcharin Loilome; Bandit Thinkhamrop; Narong Khuntikeo
Journal:  Int J Gen Med       Date:  2020-11-26

Review 6.  Benign biliary neoplasms and biliary tumor precursors.

Authors:  Samantha Sarcognato; Diana Sacchi; Matteo Fassan; Luca Fabris; Massimiliano Cadamuro; Giacomo Zanus; Ivana Cataldo; Claudia Covelli; Paola Capelli; Alberto Furlanetto; Maria Guido
Journal:  Pathologica       Date:  2021-06

7.  Surgical treatment of mucin-producing cholangiocarcinoma arising from intraductal papillary neoplasm of the intrahepatic bile duct: a report of 2 cases.

Authors:  Namsrai Baterdene; Shin Hwang; Jong-Wook Lee; Min-Jae Jung; Heeji Shin; Hye Kyoung Seo; Myeong-Hwan Kim; Sung-Koo Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2016-08-29

8.  Long-term observation and treatment of a widespread intraductal papillary neoplasm of the bile duct extending from the intrapancreatic bile duct to the bilateral intrahepatic bile duct: A case report.

Authors:  Daisuke Hokuto; Takeo Nomi; Satoshi Yasuda; Takahiro Yoshikawa; Kohei Ishioka; Takatsugu Yamada; Takahiro Akahori; Kenji Nakagawa; Minako Nagai; Kota Nakamura; Shinsaku Obara; Hiromichi Kanehiro; Masayuki Sho
Journal:  Int J Surg Case Rep       Date:  2017-07-23

9.  Intraductal papillary neoplasm of the bile duct with rapidly progressive multicentric recurrence: A case report.

Authors:  Yumiko Kageyama; Ryuzo Yamaguchi; Shinya Watanabe; Keiji Aizu; Fumiya Sato; Atsuki Arimoto
Journal:  Int J Surg Case Rep       Date:  2018-08-19

10.  Branch-type intraductal papillary neoplasm of the bile duct treated with laparoscopic anatomical resection: a case report.

Authors:  Rumi Matono; Mizuki Ninomiya; Kazutoyo Morita; Takahiro Tomino; Yumi Oshiro; Tomoyuki Yokota; Takashi Nishizaki
Journal:  Surg Case Rep       Date:  2020-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.